Can COVID-19 pandemic boost the epidemic of neurodegenerative diseases?

A Verkhratsky, Q Li, S Melino, G Melino, Y Shi - Biology direct, 2020 - Springer
Abstract The pandemic of Coronavirus Disease 2019 (COVID-19) presents the world with
the medical challenge associated with multifactorial nature of this pathology. Indeed COVID …

SARS-CoV-2-mediated neuropathogenesis, deterioration of hippocampal neurogenesis and dementia

RK Radhakrishnan… - American Journal of …, 2022 - journals.sagepub.com
A significant portion of COVID-19 patients and survivors display marked clinical signs of
neurocognitive impairments. SARS-CoV-2-mediated peripheral cytokine storm and its …

Expression of SARS-CoV-2-related receptors in cells of the neurovascular unit: implications for HIV-1 infection

S Torices, R Cabrera, M Stangis, O Naranjo… - Journal of …, 2021 - Springer
Background Neurological complications are common in patients affected by COVID-19 due
to the ability of SARS-CoV-2 to infect brains. While the mechanisms of this process are not …

Alteration of the blood-brain barrier by COVID-19 and its implication in the permeation of drugs into the brain

H Hernández-Parra, OD Reyes-Hernández… - Frontiers in Cellular …, 2023 - frontiersin.org
Diverse neurological symptoms have been reported in patients with SARS-CoV-2 disease
(COVID-19), including stroke, ataxia, meningitis, encephalitis, and cognitive impairment …

Neurological consequences of SARS-CoV-2 infection and concurrence of treatment-induced neuropsychiatric adverse events in COVID-19 patients: navigating the …

P Borah, PK Deb, B Chandrasekaran… - Frontiers in molecular …, 2021 - frontiersin.org
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to the angiotensin-
converting enzyme 2 (ACE2) receptor and invade the human cells to cause COVID-19 …

Role of aging in blood–brain barrier dysfunction and susceptibility to SARS-CoV-2 infection: impacts on neurological symptoms of COVID-19

D Adesse, L Gladulich, L Alvarez-Rosa… - Fluids and Barriers of …, 2022 - Springer
COVID-19, which is caused by Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-
CoV-2), has resulted in devastating morbidity and mortality worldwide due to lethal …

Multiple neuroinvasive pathways in COVID-19

D Bougakov, K Podell, E Goldberg - Molecular neurobiology, 2021 - Springer
COVID-19 is a highly infectious viral disease caused by the novel coronavirus SARS-CoV-2.
While it was initially regarded as a strictly respiratory illness, the impact of COVID-19 on …

COVID-19-associated neurological disorders: the potential route of CNS invasion and blood-brain barrier relevance

A Achar, C Ghosh - Cells, 2020 - mdpi.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel human
coronavirus that has sparked a global pandemic of the coronavirus disease of 2019 (COVID …

Neuroinflammation in severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection: pathogenesis and clinical manifestations

G Cárdenas, G Fragoso, E Sciutto - Current Opinion in Pharmacology, 2022 - Elsevier
Peripheral inflammation and neuroinflammation are host-mounted to eliminate injury,
infection, or toxin to restore homeostasis. However, when inflammation persists, it may …

COVID-19: a new emerging respiratory disease from the neurological perspective

A El-Sayed, L Aleya, M Kamel - Environmental Science and Pollution …, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) has become a challenging public health
catastrophe worldwide. The newly emerged disease spread in almost all countries and …